IDO1 and invasive breast carcinoma: From a mechanistic perspective, we revealed that BRCA tumors characterized by the overexpression of IDO1 have excessive KYN production through TRP degradation in an acidic TME, exacerbating metabolic dysregulation and immune suppression.